Literature DB >> 12209364

A weak association of HLA-B*2702 with Behçet's disease.

A Gül1, F A Uyar, M Inanç, L Ocal, J H Barrett, O Aral, M Koniçe, G Saruhan-Direskeneli.   

Abstract

This study aimed to analyse the association of HLA-B alleles other than -B51 with Behçet's disease (BD). We also investigated the frequency of HLA-B alleles sharing the same natural killer cell immunoglobulin-like receptor (KIR) binding sequence with HLA-B51. Broad-genotyping of HLA-B locus by PCR-SSOP in 174 Turkish BD patients and 191 healthy controls confirmed the strong association of B*51 with BD (60.9% in BD patients, 24.6% in healthy controls, OR = 4.78). No other HLA-B allele was identified showing an association with BD after adjusting for multiple testing or by using relative predispositional effects (RPE) analysis after the deletion of B*51. HLA-B alleles reacting with the sequence specific oligonucleotide probe 23, which corresponds to the KIR binding site of B*51, were found to be positive in 127 BD patients (73%) and 90 controls (47%) (OR = 3.03, 95% CI 2-4.7). The repeated RPE analysis after separating HLA-B alleles carrying B51-KIR binding sequence as distinct alleles within a broad-type allele group revealed B*2702 allele as the only allele showing an association with BD after the deletion of B*51. Selective increase of B*2702, the only B*27 allele carrying the same KIR binding sequence with B*51, warrants investigation of the possibility of interaction of HLA molecules with KIRs on NK or other T cells in the pathogenesis of BD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12209364     DOI: 10.1038/sj.gene.6363863

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  11 in total

Review 1.  Behçet's disease: from Hippocrates to the third millennium.

Authors:  D H Verity; G R Wallace; R W Vaughan; M R Stanford
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

2.  HLA-B51 gene and its expression in association with Behçet's Disease in Denizli Province of Turkey.

Authors:  Ayfer Atalay; Sanem Yildiz-Demirtepe; Sinan Tatlipinar; Berna Sanli-Erdoğan; Veli Cobankara; Cem Yildirim; Hüseyin Bağci; Erol Omer Atalay
Journal:  Mol Biol Rep       Date:  2007-06-27       Impact factor: 2.316

3.  The association of HLA-B*27 subtypes with ankylosing spondylitis in Wuhan population of China.

Authors:  Xiang Liu; Li-Hua Hu; Yi-Rong Li; Feng-Hua Chen; Yong Ning; Qun-Feng Yao
Journal:  Rheumatol Int       Date:  2009-06-18       Impact factor: 2.631

4.  Behçet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity.

Authors:  Michael J Ombrello; Yohei Kirino; Paul I W de Bakker; Ahmet Gül; Daniel L Kastner; Elaine F Remmers
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

5.  The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.

Authors:  Nuran Turkcapar; Murat Toruner; Irfan Soykan; Olcay Tiryaki Aydintug; Hulya Cetinkaya; Nursen Duzgun; Ali Ozden; Murat Duman
Journal:  Rheumatol Int       Date:  2005-09-01       Impact factor: 2.631

Review 6.  HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies.

Authors:  Mathilde de Menthon; Michael P Lavalley; Carla Maldini; Loïc Guillevin; Alfred Mahr
Journal:  Arthritis Rheum       Date:  2009-10-15

7.  Variant in ERAP1 promoter region is associated with low expression in a patient with a Behçet-like MHC-I-opathy.

Authors:  Chrysoula Dimopoulou; Jens D Lundgren; Jon Sundal; Henrik Ullum; Pål Aukrust; Finn C Nielsen; Rasmus L Marvig
Journal:  J Hum Genet       Date:  2019-12-23       Impact factor: 3.172

Review 8.  Behçet's Disease: Do Natural Killer Cells Play a Significant Role?

Authors:  Harry Petrushkin; Md Samiul Hasan; Miles R Stanford; Farida Fortune; Graham R Wallace
Journal:  Front Immunol       Date:  2015-03-24       Impact factor: 7.561

9.  Characterization of the major histocompatibility complex locus association with Behçet's disease in Iran.

Authors:  Joana M Xavier; Fereydoun Davatchi; Olga Abade; Farhad Shahram; Vânia Francisco; Bahar Sadeghi Abdollahi; Hélder Trindade; Abdolhadi Nadji; Niloofar Mojarad Shafiee; Fahmida Ghaderibarmi; Dário Ligeiro; Sofia A Oliveira
Journal:  Arthritis Res Ther       Date:  2015-03-19       Impact factor: 5.156

10.  HLA and non-HLA genes in Behçet's disease: a multicentric study in the Spanish population.

Authors:  Marco Antonio Montes-Cano; Marta Conde-Jaldón; José Raul García-Lozano; Lourdes Ortiz-Fernández; Norberto Ortego-Centeno; María Jesús Castillo-Palma; Gerard Espinosa; Genaro Graña-Gil; Miguel Angel González-Gay; Ana Celia Barnosi-Marín; Roser Solans; Patricia Fanlo; Teresa Camps; Santos Castañeda; Juan Sánchez-Bursón; Antonio Núñez-Roldán; Javier Martín; María Francisca González-Escribano
Journal:  Arthritis Res Ther       Date:  2013-10-04       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.